Sponsor
Fondation Hôpital Saint-Joseph
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Fondation Hôpital Saint-Joseph appears in 40 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
40 shownCombinaison of Virtual Reality and Rehabilitation to Improve Muscle Function, Exercise Tolerance, Exertional Symptoms and Dyspnea in Patients With Chronic Respiratory Disease: a Randomized Cross-over TrialNCT06811402 · lead sponsor · 2026-09-01
NOT_YET_RECRUITINGShort- and Mid-term Therapeutic, Prognostic, and Societal Impact of Implementing Intraoperative Assessment of Pulmonary Resection Quality for Lung CancerNCT07828938 · lead sponsor · 2026-09-01
NOT_YET_RECRUITINGEffect of Vasopressin Versus Norepinephrine on Post-operative Mean Pulmonary Arterial Pressure Following Pulmonary Endarterectomy Surgery,NCT07614438 · lead sponsor · 2026-08-01
NOT_YET_RECRUITINGPrevalence and Functional Impact of Urinary Incontinence in Women With Chronic Obstructive Pulmonary Disease Undergoing Rehabilitation: a Cross-sectional StudyNCT07134400 · lead sponsor · 2026-02-02
NOT_YET_RECRUITINGInfluence of Diabetic Control on the Degree of Liver Fibrosis Assessed by Non-invasive Scores in Patients Followed in DiabetologyNCT05605821 · lead sponsor · 2024-01-15
UNKNOWNAssessment of the Cerebral Perfusion During the Period of Deep Hypothermia at 18°C in Patient Undergoing Pulmonary Endarterectomy Surgery.NCT06250374 · lead sponsor · 2023-08-24
ACTIVE_NOT_RECRUITINGSatisfaction Survey for the Outpatient Unit Dedicated to Post-cancer TreatmentNCT05530824 · lead sponsor · 2022-07-18
COMPLETEDEffectiveness and Safety of Preoperative Magnetic Detection of Non-palpable Breast LesionsNCT05327218 · lead sponsor · 2022-03-20
COMPLETEDStudy of the Impact of the COVID-19 Pandemic on the Management of Type 2 Diabetic Patients in a Sample in the Paris RegionNCT05175677 · lead sponsor · 2022-03-10
COMPLETEDPredictors of Non-accESs to therapeutiC EducAtion Programs Among Patients With Type 2 Diabetes, and/or Asthma, and/or Chronic Heart Failure in an Emergency SettingNCT05320276 · lead sponsor · 2022-02-28
COMPLETEDInterest of GLP1 Analogues in Overweight Type 2 Diabetic Patients With Chronic Inflammatory Bowel DiseaseNCT05196958 · lead sponsor · 2022-01-25
UNKNOWNStudy Comparing the Kinetics of Endothelial Cell Loss Associated With the XEN® Implant Versus Traditional Filtering Surgery for GlaucomaNCT04781283 · lead sponsor · 2021-11-15
WITHDRAWNCorrelation Between Seminal Vesicle Size and Duration of Sexual AbstinenceNCT05192252 · lead sponsor · 2021-11-02
UNKNOWNDeep Sclerectomy vs Xen in Solo ProcedureNCT05201378 · lead sponsor · 2021-07-15
COMPLETEDEfficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis PatientsNCT04529278 · lead sponsor · 2021-01-18
UNKNOWNEffect of the Duration of Pre-oxygenation on Apnea Tolerance in Obese Patients During the Induction of General AnesthesiaNCT04699435 · lead sponsor · 2021-01-13
UNKNOWNEvaluation of a Back-to-home Support Program for Hospitalized Patients for Heart FailureNCT05566145 · lead sponsor · 2020-12-15
UNKNOWNImpact of the COVID-19 Epidemic on the Hospital Journey of Patients With Cancer of the Digestive SystemNCT04616950 · lead sponsor · 2020-12-01
COMPLETEDEvaluation of the Program to Help Return Home Patients Hospitalized for Heart Failure, From Paris Saint-Joseph HospitalNCT04613973 · lead sponsor · 2020-11-28
COMPLETEDImpact of COVID-19 on the Benefit of Cardiac RehabilitationNCT04513964 · lead sponsor · 2020-11-01
WITHDRAWNEvaluation of the Impact of the Use of Hypnotherapy Performed by a Virtual Reality Toolalong the Care Pathway of Patients Undergoing Breast Cancer Treatment.NCT04574609 · lead sponsor · 2020-09-24
UNKNOWNOCT Angiography in the Glaucoma DiagnosisNCT04437446 · lead sponsor · 2020-07-21
UNKNOWNProspective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 PandemicNCT04437719 · lead sponsor · 2020-06-29
COMPLETEDEvaluation of the Written Information Delivered by the General Practitioner of the Patients Presenting to the Emergency Room for an Aggravation of AsthmaNCT04048746 · lead sponsor · 2019-07-24
TERMINATEDEvaluation of the Benefit of Traditional Karate in Heart Failure for Cardiac RehabilitationNCT03884855 · lead sponsor · 2019-04-04
COMPLETEDDevelopment of a Predictive Algorithm for the Risk of Rehospitalization of Patients With Heart FailureNCT03905226 · lead sponsor · 2019-01-12
COMPLETEDComparative Effectiveness and Tolerance of Subliminal Subthreshold Transscleral CyclophotocoagulationNCT03961035 · lead sponsor · 2018-10-12
COMPLETEDEvaluation of the Impact of the XEN® Implant on Endothelial Cell Density, 3 Years After SurgeryNCT05904613 · lead sponsor · 2018-10-09
COMPLETEDEvaluation of the Electroretinogram Pattern (Diopsys® NOVA System) for the Early Diagnosis of GlaucomaNCT03642782 · lead sponsor · 2018-07-03
UNKNOWNEvaluation of the Xen Implant in Glaucoma SurgeryNCT03733600 · lead sponsor · 2018-06-15
COMPLETEDStudy of Left Ventricular Function of Patients With Type 2 Diabetes Without Cardiovascular DiseaseNCT03736668 · lead sponsor · 2018-05-22
UNKNOWNEvaluation of the Efficacy of Selecta Laser Trabeculoplasty in Patients Undergoing Filtering SurgeryNCT05900063 · lead sponsor · 2018-01-01
COMPLETEDPhase II Study of Afatinib as Third- or Further-line Treatment for Patients With Stage IV Bronchial Adenocarcinoma, Harboring Wild-type EGFR, Expressing the Neurotensin - Neurotensin Receptor ComplexNCT02876081 · lead sponsor · 2017-09-01
WITHDRAWNImpact of Pharmacist in Cardiology ServiceNCT03206294 · lead sponsor · 2017-03-08
COMPLETEDRetrospective Analysis of the Expression of the Neurotensin Receptor by Metastatic Lung AdenocarcinomasNCT02891733 · lead sponsor · 2017-03-06
WITHDRAWNScreening of Tobacco-induced Cancers by Low-dose CT-scanner and Identification of Circulating Tumor CellsNCT02849041 · lead sponsor · 2017-01-23
UNKNOWNImpact of Myotensives Techniques, With and Without Auto-reeducation, on the Vital Capacity Forced by the Patient Affected by a Honeymoon Parkinson's DiseaseNCT03313973 · lead sponsor · 2016-12-05
COMPLETEDHow Diabetic Patient Are Taken Care in Cardiology Service Actually?NCT03172247 · lead sponsor · 2016-12-01
COMPLETEDKinetics of Circulating Tumoral Cells in Bronchial Primitive CancerNCT03328559 · lead sponsor · 2016-03-07
COMPLETEDAssessment of the Prevalence of Small Fiber Peripheral Neuropathy Among Non-diabetic Obese PatientsNCT02767583 · lead sponsor · 2015-03-02
COMPLETEDDrugs studied in this sponsor's trials
4 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Fondation Hôpital Saint-Joseph as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
afatinib1
liraglutide1
norepinephrine1
vasopressin (USP)1
afatinib RxCUI 1430438 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
liraglutide RxCUI 475968 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
norepinephrine RxCUI 7512 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
vasopressin (USP) RxCUI 11149 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
Sponsor roles
lead sponsor40
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.